Moderna Stands Alone With Single-Antigen Approach To COVID-19 Vaccine
Targeting SARS-CoV-2 Spike Protein Is Sensible, Analyst Says
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
